164 related articles for article (PubMed ID: 11745262)
1. COX-2 expression in dysplasia of the head and neck: correlation with elF4E.
Nathan CO; Leskov IL; Lin M; Abreo FW; Shi R; Hartman GH; Glass J
Cancer; 2001 Oct; 92(7):1888-95. PubMed ID: 11745262
[TBL] [Abstract][Full Text] [Related]
2. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinoma.
Kase S; Osaki M; Honjo S; Hashimoto K; Adachi H; Tsujitani S; Ito H
Pathobiology; 2004; 71(2):84-92. PubMed ID: 14707443
[TBL] [Abstract][Full Text] [Related]
4. COX-2 inhibition in upper aerodigestive tract tumors.
Altorki NK; Subbaramaiah K; Dannenberg AJ
Semin Oncol; 2004 Apr; 31(2 Suppl 7):30-6. PubMed ID: 15252927
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer.
Mohan S; Epstein JB
Oral Oncol; 2003 Sep; 39(6):537-46. PubMed ID: 12798395
[TBL] [Abstract][Full Text] [Related]
6. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
Chan G; Boyle JO; Yang EK; Zhang F; Sacks PG; Shah JP; Edelstein D; Soslow RA; Koki AT; Woerner BM; Masferrer JL; Dannenberg AJ
Cancer Res; 1999 Mar; 59(5):991-4. PubMed ID: 10070952
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract.
Dannenberg AJ; Altorki NK; Boyle JO; Lin DT; Subbaramaiah K
Ann N Y Acad Sci; 2001 Dec; 952():109-15. PubMed ID: 11795429
[TBL] [Abstract][Full Text] [Related]
9. [A study on cyclooxygenase-2 protein expression in esophageal carcinoma and premalignant lesions].
Wang L; Zhang W; Wang W
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):14-6. PubMed ID: 11783060
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.
Gallo O; Franchi A; Magnelli L; Sardi I; Vannacci A; Boddi V; Chiarugi V; Masini E
Neoplasia; 2001; 3(1):53-61. PubMed ID: 11326316
[TBL] [Abstract][Full Text] [Related]
11. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma.
Lim SC; Park SY; Do NY
Oncol Rep; 2003; 10(5):1073-9. PubMed ID: 12883661
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma.
Gallo O; Masini E; Bianchi B; Bruschini L; Paglierani M; Franchi A
Hum Pathol; 2002 Jul; 33(7):708-14. PubMed ID: 12196922
[TBL] [Abstract][Full Text] [Related]
13. Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma.
Jaeckel EC; Raja S; Tan J; Das SK; Dey SK; Girod DA; Tsue TT; Sanford TR
Arch Otolaryngol Head Neck Surg; 2001 Oct; 127(10):1253-9. PubMed ID: 11587608
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression.
Zeng Q; McCauley LK; Wang CY
J Biol Chem; 2002 Dec; 277(51):50137-42. PubMed ID: 12393863
[TBL] [Abstract][Full Text] [Related]
15. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
[TBL] [Abstract][Full Text] [Related]
16. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
[TBL] [Abstract][Full Text] [Related]
17. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
Koga H
Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions.
Wardlaw SA; March TH; Belinsky SA
Carcinogenesis; 2000 Jul; 21(7):1371-7. PubMed ID: 10874016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
